Background The Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE) index has been recommended as an ideal indicator of body fat and exhibited significant correlation with cardiometabolic risk factors. However, whether the CUN-BAE index correlates with incident diabetes in Asian populations is unknown. Therefore, this longitudinal study was designed to evaluate the association between baseline CUN-BAE index and type 2 diabetes mellitus (T2DM). Methods This retrospective longitudinal study involved 15,464 participants of 18–79 years of age in the NAGALA (NAfld in the Gifu Area Longitudinal Analysis) study over the period of 2004–2015. Cox proportional hazards regression was performed to test the relationship between the baseline CUN-BAE index and diabetes incidence. Further stratification analysis was conducted to ensure that the results were robust. The diagnostic utility of the CUN-BAE index was tested by the receiver operating characteristic (ROC) curve. Results Over the course of an average follow-up of 5.4 years, 373 (2.41%) participants developed diabetes. A higher diabetes incidence was associated with higher CUN-BAE quartiles (P for trend< 0.001). Each 1 unit increase in CUN-BAE index was associated with a 1.08-fold and 1.14-fold increased risk of diabetes after adjustment for confounders in males and females, respectively (both P < 0.001). Stratification analysis demonstrated a consistent positive correlation between baseline CUN-BAE and diabetes incidence. Moreover, based on ROC analysis, CUN-BAE exhibited a better capacity for diabetes prediction than both body mass index (BMI) and waist circumference (WC) in both sexes. Conclusions The baseline CUN-BAE level was independently related to the incidence of diabetes. Increased adiposity determined by CUN-BAE could be used as a strong nonlaboratory predictor of incident diabetes in clinical practice.
Background The Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE) index has been recommended as an ideal indicator of body fat and exhibited significant correlation with cardiometabolic risk factors. However, the relationship between the CUN-BAE index and incident diabetes in the Asian population remains unclear. Therefore, this longitudinal study was designed to evaluate the impact of the baseline CUN-BAE index on diabetes. Methods This retrospective longitudinal study involved 15,464 participants aged 18–79 in the NAGALA (NAfld in the Gifu Area Longitudinal Analysis) study between 2004 and 2015. The association between the baseline CUN-BAE index and diabetes incidence was tested by cox proportional-hazards regression. And the stratification analysis was further conducted to verify the robustness of the results. The ROC curve was applied to evaluate the diagnostic utility of the CUN-BAE index, and the area under the ROC curve was calculated. Results During an average of 5.4 years of follow-up, 373 (2.41%) participants were diagnosed with diabetes. A higher diabetes incidence was associated with ascending CUN-BAE quartiles (P for trend < 0.001). Each 1 standard deviation (SD) increased in CUN-BAE index was associated with a 1.4104-fold and 1.8954-fold increased risk of diabetes after adjustment for confounders in males and females, respectively (both P < 0.001). Stratification analysis demonstrated a consistent positive correlation between baseline CUN-BAE and diabetes incidence. Moreover, CUN-BAE exhibited a better capacity to predict diabetes than both BMI and WC in different genders according to ROC analysis. Conclusions The baseline CUN-BAE level was independently related to incident diabetes. Increased adiposity appraised with CUN-BAE could be used as a strong nonlaboratory predictor of incident diabetes in clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.